Cell therapy associated with guided bone regeneration (GBR) can be used to treat bone defects under challenging conditions such as osteoporosis. This study aimed to evaluate the effect of mesenchymal stem cells (MSCs) in combination with a poly(vinylidenetrifluoroethylene)/barium titanate (PVDF-TrFE/BT) membrane on bone repair in osteoporotic rats. Osteoporosis was induced in female rats by bilateral removal of the ovaries (OVX) or sham surgery (SHAM), and the osteoporotic condition was characterized after 5 months by microtomographic and morphometric analyses. Calvarial defects were created in osteoporotic rats that immediately received the PVDF-TrFE/BT membrane. After 2 weeks, bone marrow-derived MSCs from healthy rats, characterized by the expression of surface markers using flow cytometry, or phosphate-buffered saline (PBS) (Control) were injected into the defects and bone formation was evaluated 4 weeks post-injection by microtomographic, morphometric, and histological analyses. A reduction in the amount of bone tissue in the femurs of OVX compared with SHAM rats confirmed the osteoporotic condition of the experimental model. More bone formation was observed when the defects were injected with MSCs compared to that with PBS. The modification that we are proposing in this study for the classical GBR approach where cells are locally injected after a membrane implantation may be a promising therapeutic strategy to increase bone formation under osteoporotic condition.
Introduction
After experiencing damage due to trauma, surgical interventions, or pathologies, bone tissue can be repaired by a regeneration process that resembles the skeletal development. On the other hand, there are several situations where the exuberant healing capacity of bone tissue is surpassed by the extent of the damage or the concurrence of systemic conditions that disturb tissue metabolism. Among the systemic conditions, osteoporosis is the most prevalent bone pathology that has been reported to affect more than 200 million people around the world and has generated an estimated medical cost of 8 billion dollars in the United States in 2008. 1, 2, 3 Declaration of Interests: The authors certify that they have no commercial or associative interest that represents a conflict of interest in connection with the manuscript.
Osteoporosis occurs due to an imbalance in the process of bone remodeling that results in the degradation of bone microarchitecture and the reduction of tissue density, thereby increasing skeletal fragility and fracture risk. 4 The occurrence of trauma or performing surgical procedures in the presence of osteoporosis represents a challenging condition that may require additional treatments such as bone grafts (autograft and allograft), biomaterials, and growth factors. 5 However, these treatments could present some drawbacks, and there has been a growing interest for new treatment approaches such as bone tissue engineering and cell therapy.
The principle of guided bone regeneration (GBR) involves the use of membranes as barriers, and GBR has been extensively used in the fields of maxillofacial surgery and periodontology to improve bone healing. 6, 7 Recent research has demonstrated promising results using GBR in terms of bone repair of osteoporotic rat calvarial defects, wherein there was induction of more bone formation than that in untreated defects. 8 Although there was increment in bone repair induced by the composite poly(vinylidene-trifluoroethylene)/ barium titanate (PVDF-TrFE/BT) membrane under osteoporotic condition, only small amount of bone formation was observed. This could be, at least in part, due to a decreased migration of mesenchymal stem cells (MSCs) to the defects induced by osteoporosis as it is well known that MSC migration and invasion of injured areas are critical to the process of bone healing. 9, 10 In this context, in our earlier study, we had combined GBR with cell therapy using an approach where the composite PVDF-TrFE/BT membrane was implanted into the bone defects and 2 weeks postimplantation cells were injected into the membrane. 11 Considering that this approach was beneficial to bone repair in the calvarial defects of normal rats compared with GBR alone, 11 we hypothesized that the combination of cell therapy and GBR induces more bone formation than GBR alone under osteoporotic condition. To test our hypothesis, osteoporosis was induced in female rats by bilateral ovariectomy, and then calvarial defects were created and immediately implanted with PVDF-TrFE/BT membranes. After 2 weeks, MSCs were injected into the defects and bone formation was evaluated 4 weeks post-injection by microtomographic, morphometric, and histological analyses.
Methodology

Osteoporosis induction
The experimental procedures using animals were carried out under the guidelines of the Committee of Ethics in Animal Research (Protocol # 2014.1.795.58.0). Osteoporosis was induced by bilateral ovariectomy. 12 Fourteen female Wistar rats weighing 150 g were anesthetized by injecting a combination of ketamine (7 mg/100 g body weight; Agener União, São Paulo, Brazil) and xylazine (0.6 mg/100 g body weight; Calier, MG, Brazil) to be ovariectomized (OVX). A bilateral abdominal incision was performed to expose and remove the ovaries, and the skin was sutured with nylon 4.0 (Ethicon, São Paulo, Brazil). Then, single doses of antibiotics and analgesics were administered. Another set of four female Wistar rats were submitted to the same surgical procedure, with the exception of the excision of ovaries, to reproduce the effects of the surgical stress (SHAM). After 5 months, osteoporosis was characterized and the OVX animals were used for all the subsequent experiments.
Characterization of osteoporotic condition
The distal epiphysis of the femurs and the calvarial fragments (removed to create bone defects) of OVX and SHAM rats were used to characterize osteoporosis by microtomographic and morphometric analyses. The animals (n = 4 in each group, OVX and SHAM) were euthanized, and the femurs were removed and stored in 10% formalin buffered with 0.1 M sodium cacodylate, pH 7.0 (Merck, HE, Germany). The calvarial fragments (n = 5 in each group, OVX and SHAM) were obtained during the creation of the bone defects as described below and stored in the same solution used for the femurs. Morphometric analysis was carried out using high-resolution SkyScan 1172 microtomograph (Bruker, Kontich, Belgium). The images were obtained at 9.8 pixel size, 60 kVp, and 165 mA, and the NRecon software (version 1.6.10.4, Bruker) was used for the reconstructions with the following parameters: smoothing set at 2, ring artifact correction set at 6, and beam hardening correction set at 20%. The reconstructions were analyzed by the CTAn software (version 1.15.4.0, Bruker) to evaluate bone mineral density. 13, 14 Isolation and culture of MSCs Bone marrow cells were flushed from the femurs of healthy male Wistar rats (n = 3, weighing 250-300 g), pooled, and cultured in alpha minimum essential medium (Gibco-Invitrogen, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (Gibco-Invitrogen), 50 µg/ml gentamicin (Gibco-Invitrogen), and 0.3 µg/ml fungizone (Gibco-Invitrogen). After 48 h, the medium was refreshed allowing the selection of MSCs by adherence to the tissue plastic culture and expansion until subconfluence. Then, the MSCs were enzymatically released and injected into the calvarial defects as described below. The cells were kept at 37°C and humidified atmosphere containing 5% CO 2 and 95% air, and the medium was changed every 72 h.
Characterization of MSCs
Subconfluent MSCs (2 × 10 5 cells per tube) were incubated separately with monoclonal anti-rat antibodies against CD29, CD31, CD90, CD106 (BD Biosciences, Franklin Lakes, NJ, USA), and CD34 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) for 30 min at room temperature. Then, the cells were homogenized using 2 ml phosphate-buffered saline (PBS, Gibco-Invitrogen)/Tween-20 (Sigma-Aldrich) and centrifuged at 360 g for 5 min. The cell pellet was washed with PBS (Gibco-Invitrogen), and 500 µl of formaldehyde (Merck, Germany) diluted in PBS (Gibco-Invitrogen) were added. Flow cytometry was performed in a FACSCanto™ system (BD Biosciences), and data were presented as percentage of cells expressing each surface marker.
In vivo bone formation
Ten OVX rats were anesthetized as described above. A skin incision was performed to expose the parietal bone, and a unilateral 5-mm diameter calvarial defect was created and immediately implanted with the PVDF-TrFE/BT membrane positioned between dura mater and inner calvaria cortical bone. The PVDF-TrFE/BT membrane was used as it can promote bone formation in both normal and osteoporotic rats. 8, 11 The defect size was selected based on previous studies where no significant bone formation was observed even 12 weeks post-surgery. 15, 16 Two weeks postimplantation, the animals were randomly distributed to receive local injections of 50 µl of PBS (Gibco-Invitrogen) containing 5 × 10 6 MSCs collected from healthy rats (n = 5) or 50 µl of PBS without MSCs (Control, n = 5). The number of cells was selected on the basis of a previous study that used different cell concentrations (data not shown) and on data published in the literature. 17 These procedures were performed with caution to deliver the injection content into the bone defects on the top of the PVDF-TrFE/BT membrane. Four weeks post-injection, the rats were euthanized, and the calvariae were harvested and processed for morphometric and histological analyses.
Considering the 5-mm diameter defect and the average thickness of the calvaria, the selected region of interest (ROI) was 5-mm diameter × 0.6-mm thickness. The segmentation of bone was defined in the range of 60-110 in a histogram gray scale from 0 to 255 to isolate bone tissue from the membrane. To quantify only the bone formation induced by the injection containing either MSCs or PBS, the morphometric analysis was carried out only into the defect, on the top of the PVDF-TrFE/BT membrane, delimited by the selected ROI, and according to the American Society for Bone and Mineral Research. The following parameters were generated: bone volume, bone volume/total volume, bone surface, bone mineral density, trabecular thickness, trabecular number, and trabecular separation. 13, 14 After conducting the microtomographic and morphometric analyses, the samples were processed to obtain undecalcified tissue sections as described elsewhere. 11 The histological description of the tissues grown on top of the PVDF-TrFE/BT membrane was made from images obtained using a light microscope (Leica Microsystems Wetzlar GmbH, Germany) equipped with a digital camera (DFC 310 FX camera, Leica Microsystems).
Statistical analysis
All data were expressed as mean ± standard deviation. The data of osteoporosis characterization (power: 0.99) and bone formation (power: 0.81) were compared using the Student's t-test, and the level of significance was set at p ≤ 0.05. Power calculations were performed using the statistical power analysis software from the Universität Düsseldorf (http:// www.gpower.hhu.de) considering the sample sizes used in this study.
Results
Characterization of osteoporotic condition
Three-dimensional reconstructed microtomographic images revealed that OVX ( Figure 1A ) and SHAM ( Figure 1B ) femurs displayed different bone structure. The OVX femurs ( Figure 1A) exhibited larger dimensions and altered external contour with reduction of trabecular density compared with SHAM ( Figure 1B) , in addition to a lower bone mineral density (p = 0.001) than that of SHAM ( Figure 1C ). Regarding calvarial fragments, a similar bone morphology was observed by comparing OVX ( Figure 1D ) and SHAM ( Figure 1E ) with calvaria from OVX, which exhibited a lower bone mineral density than SHAM ( Figure 1F ).
Characterization of MSCs
The fluorescence background of nonlabeled cells was 3.5% (Figure 2A) , which was subtracted from each percentage of the labeled cells. The MSCs harvested from healthy rats exhibited a low expression of CD31 ( Figure 2B ) and CD34 ( Figure 2C ), both of which are hematopoietic markers, an intermediate expression of CD106 ( Figure 2D) , and a high expression of CD29 ( Figure 2E ) and CD90 ( Figure 2F) ; the latter three are markers of MSCs. Taken together, these data indicate that the majority of this cell population is composed of MSCs.
In vivo bone formation
Three-dimensional reconstructed microtomographic images demonstrated the formation of bone tissue in all the defects irrespective of the treatment ( Figure 3A and B). However, it was evident that injection of MSCs induced higher bone formation ( Figure 3A ) than that with PBS injection ( Figure 3B ). Moreover, MSCs induced bone formation in the middle of the defects ( Figure 3A) , whereas PBS induced bone formation primarily in the periphery ( Figure 3B ). Confirming these observations, the morphometric analysis revealed that bone volume ( Figure 3C , p = 0.05), bone volume/total volume ( Figure 3D , p = 0.02), bone mineral density ( Figure 3F , p = 0.001), and trabecular number ( Figure 3H , p = 0.03) were higher in defects treated with MSCs than in defects treated with PBS. Bone surface ( Figure 3E , p = 0.07), trabecular thickness ( Figure 3G , p = 0.55), and trabecular separation ( Figure  3I , p = 0.89) were not statistically different between MSC and PBS treatments.
Results of the histological sections confirmed the morphometric results. On the top of the PVDF-TrFE/BT membrane, more bone tissue was observed almost bridging the defects treated with MSCs compared with those treated with PBS ( Figure 4A and B). A common thin layer of connective tissue between the PVDF-TrFE/BT membrane and the newly formed bone without inflammatory signs was observed in both treatments ( Figure 4C and D) .
Discussion
This study aimed to evaluate bone formation in osteoporotic rats induced by the combination of cell therapy and GBR. Osteoporosis was induced in female rats by bilateral ovariectomy (OVX), and then calvarial defects were created and immediately implanted with PVDF-TrFE/BT membrane. After 2 weeks, either MSCs or PBS (Control) was injected into the defects on the top of the membrane, and bone formation was evaluated 4 weeks postinjection by microtomographic, morphometric, and histological analyses. Bone formation was observed irrespective of the treatment, but a significantly higher amount of bone tissue was detected in the defects treated with the combination of MSCs and the membrane.
The experimental model selected was that of OVX rats, in which estrogen deficiency induces osteoporosis, with the consequent loss of bone mass and its sequelae, similar to that found in postmenopausal women. 18, 19 The induction of osteoporosis by OVX in rats is one of the most suitable models as it affects several bones. 20 In the present study, the analyses were limited to the trabecular bone microarchitecture of the distal epiphysis of the femurs as it is a region that is particularly sensitive to the effects of OVX and recognized as a key component of quality and bone strength (resistance), comparable to osteoporosis in humans and detectable by microtomography. 18, 21, 22, 23, 24 The results revealed low bone quality of the femurs of OVX rats compared with SHAM rats. However, the lack of a statistically significant difference between the groups in terms of trabecular thickness may be associated with trabecular thickening in osteoporotic rats as an attempt to compensate for the decrease in bone resistance produced by trabecular resorption. 25 Results of the microtomographic and morphometric analyses confirmed the osteoporotic pattern of the selected experimental model and substantiate the results described in the literature. 20, 26, 27, 28 One of the critical factors to the success of GBR technique is the choice of a suitable membrane 7 . In this study, we selected the PVDF-TrFE/BT membrane due to its good in vitro biocompatibility and the capacity to induce bone formation in both normal and osteoporotic rats and decrease bone resorption by inhibiting osteoclastogenesis. 8, 29, 30, 31, 32, 33 In addition, in a previous study, the PVDF-TrFE/BT membrane was successfully combined with osteoblast injections to increase the amount of bone formation in the calvarial defects of normal rats. 11 For bone regeneration based on the use of cells, several tissues have been investigated as cell source; however, the bone marrow still remains the most common source, at least in part, due to its ease of accessibility and multilineage differentiation potential. 34 In fact, we had previously demonstrated the ability of these cells to differentiate into multilineages, 35 which was associated with the expression of cell surface markers described in the present study, thus allowing to qualify them as MSCs. In this study, we opted for using these bone marrowderived MSCs harvested from healthy animals based on previous reports where these cells either undifferentiated or differentiated into osteoblasts displayed similar potential to induce bone formation, combined with the fact that bone marrow-derived cells induced more bone formation than adiposederived cells. 11, 36 Furthermore, the cell injection was performed 2 weeks post-surgery to prevent the contact of MSCs with the initial inflammatory microenvironment of the bone defect, which could induce apoptosis. 37 It is worth noting that the use of the same approach, membrane implantation 2 weeks before cell injection, revealed that the cells remained in the bone defect for up to 25 days. 11 As mentioned earlier, the strategy of combining GBR with cell therapy has been used to increase bone formation in rat calvarial defects. 11, 38, 39 The combination of MSCs with either synthetic β-tricalciumphosphate or collagen membrane enhanced bone formation compared with the use of biomaterials implanted without cells in rat calvarial defects. 38, 39 In this study, we present evidence that this approach is also effective in the presence of osteoporosis. In fact, some of the morphometric parameters and the microtomographic and histological images revealed higher amount of bone formation in those defects injected with MSCs than in the defects treated with PBS after the implantation of the PVDF-TrFE/BT membrane. Since the morphometric analysis was carried out only into the bone tissue found in the defect, on the top of the membrane, the results confirmed that the cells were effective in increasing bone formation. In addition, the evaluation of bone mineral density revealed that MSCs yield more mineralized bone tissue. Comparison of the morphometric parameters of defects treated with PVDF-TrFE/BT membranes without cells in osteoporotic rats described in this study and in normal rats described elsewhere 11 revealed more bone formation in normal rats, thus confirming that osteoporosis impairs the process of bone repair. 40 Interestingly, the pattern of bone formation was different between the treatments, wherein it was spread out in the MSC-injected defects, whereas in the PBS-injected defects, the bone formation was limited to the periphery. In common, both treatments resulted in an intervening connective tissue between bone tissue and the PVDF-TrFE/BT membrane, which appears to be a characteristic of this membrane. 30
Conclusion
We have demonstrated that the proposed modification of the classical GBR approach, which involves local injection of cells after the implantation of a membrane, is effective in increasing bone formation in the presence of osteoporosis. It is worth noting that none of the defects treated with GBR and cell injection exhibited complete bone repair. As MSCs were used after harvesting and expansion, future studies should consider the use of the combination of cells with growth factors or the use of genetically modified cells in an attempt to improve the osteogenic potential of these cell populations to induce complete bone regeneration.
